BridgeMD
Compares treatment options for Head and Neck Cancers
Official title StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
ClinicalTrials.gov ID: NCT03394417
What this study is testing
- What it's testing
- This is a phase IV, prospective, double-blind, randomized controlled trial with 2 study arms. The study population will be patients receiving chemoradiation for head and neck carcinomas, the majority of whom will be outpatients unless they require inpatient supportive care during treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80
You may be able to join if
- patients who are 21 years of age or older
- histological diagnosis of head and neck carcinoma available
- patients who are to be treated with concurrent chemoradiation
- Eastern Cooperative Oncology Group (ECOG) performance status 0 to 3
- no known allergy to StrataXRT or silicone
You likely can't join if
- patients who cannot apply the skin product or have it administered to them
- patients with comorbidities and/or on medications that may alter the response of the skin e.g. connective tissue disorder
- patients with existing rashes or wounds in the radiation field at baseline
- patients receiving concurrent cetuximab during radiotherapy
- previous radiotherapy to the head and neck region
- female patients who are pregnant or breast feeding
See the full eligibility criteria
- patients who are 21 years of age or older
- histological diagnosis of head and neck carcinoma available
- patients who are to be treated with concurrent chemoradiation
- Eastern Cooperative Oncology Group (ECOG) performance status 0 to 3
- no known allergy to StrataXRT or silicone
- able to give written informed consent, or have written consent given on their behalf
- patients who cannot apply the skin product or have it administered to them
- patients with comorbidities and/or on medications that may alter the response of the skin e.g. connective tissue disorder
- patients with existing rashes or wounds in the radiation field at baseline
- patients receiving concurrent cetuximab during radiotherapy
- previous radiotherapy to the head and neck region
- female patients who are pregnant or breast feeding
- unable to give written informed consent , or are unable to have written consent given on their behalf
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.